l9n/ Oregon

2015 Regular Session

House Bill 3486

Requires manufacturer of prescription drug with annual wholesale acquisition cost of $10,000 or more, or with wholesale acquisition cost of $10,000 or more per course of treatment, to file annual report with Oregon Health Authority on costs associated with prescription drug for previous calendar year.

Did not become law. It stopped in the House of Representatives's Health Care Committee on July 6, 2015. The 2015 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Requires manufacturer of prescription drug with annual wholesale acquisition cost of $10,000 or more, or with wholesale acquisition cost of $10,000 or more per course of treatment, to file annual report with Oregon Health Authority on costs associated with prescription drug for previous calendar year.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

1 co-sponsor

Rob Nosse

In the Senate

    2 co-sponsors

    Jeff Kruse, Laurie Monnes Anderson

    Its course

    March 11 to July 6, 2015, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

    Each committee stop sits inside its chamber.

    Every action5 actions on 4 days

    In the House of RepresentativesMar 11 to Jul 6 · stopped117 days

    Waiting for a committeeMar 11 to Mar 110 days

    Health CareMar 11 to Jul 6 · stopped117 days

    Text

    Each version as the Legislative Assembly printed it.

    l9n doesn't hold this bill's text yet.

    What happened

    In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

    In the House of Representatives Mar 11 – Jul 6

    1. Introduced
    2. Sent to Health Care
    3. Heard in Health Care
    4. Heard in Health Care
    5. Died when the session ended
    All 5 actions, as published